MAPT and Alzheimer disease: The primary biomarkers in AD are amyloid beta (Aβ), specifically its hyperphosphorylated isoform Aβ42, total tau protein (t-tau), and phosphorylated tau protein (p-tau), more specifically its phosphorylated form at position 181 (p-tau181).